AstraZeneca will cut deliveries of the Oxford COVID-19 vaccine to the European Union by 60% in the first quarter of the year, according to Reuters news agency.
The company was expected to deliver around 80 million doses to the 27 EU countries by the end of March, an EU official told the agency.
However, it now expects that to be cut to 31 million doses due to “production problems” at a vaccine factory in Belgium run by its partner Novasep.
“Initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain,” a company spokesman said in a written statement.
The EU Commission said AstraZeneca had informed its vaccination steering board of a change of its delivery schedule and that the Commission was working to find out more.
The immunisation campaign has already been hampered by a temporary shortfall in the supply chain of vaccine developers Pfizer and BioNTech, who are retooling a site in Belgium to boost output.
Earlier the Financial Times reported that supplies to the UK would not be affected.
Source : Sky News